Non-comparative phase II study of bendamustine hydrochloride in patients with pretreated soft tissue sarcoma (German Sarcoma Group-AIO 001).

被引：0
|
作者：
Mayer, F.
Schleicher, J.
Huober, J.
Meisinger, I.
Pintoffl, J.
Kaefer, G.
Gruenwald, V.
Burkart, C.
Kanz, L.
Hartmann, J. T.
机构：
[1] Univ Tuebingen, Tubingen, Germany
[2] Katharinen Hosp, D-70174 Stuttgart, Germany
[3] Krankenhaus Sigmaringen, Sigmaringen, Germany
[4] Hannover Med Sch, D-3000 Hannover, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9525
引用
收藏
页码：526S / 526S
页数：1
相关论文
共 50 条
  • [31] Preoperative chemoradiation therapy for localized retroperitoneal soft tissue sarcoma (RSTS): A phase II study from the Italian Sarcoma Group.
    Gronchi, A.
    De Paoli, A.
    Dani, C.
    Merlo, F.
    Quagliuolo, V.
    Grignani, G.
    Bertola, G.
    Navarria, P.
    Dei Tos, A. P.
    Casali, P. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [32] A randomized phase II study of durvalumab and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma (MEDISARC, AIO-STS 0415).
    Gruenwald, Viktor
    Bauer, Sebastian
    Hermes, Barbara
    Ivanyi, Philipp
    Lindner, Lars H.
    Pink, Daniel
    Reichardt, Peter
    Richter, Stephan
    Tuchscherer, Armin
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Exatecan (DX-8951f), a new topoisomerase I-inhibitor, is inactive in heavily pretreated patients (pts.) with advanced soft tissue sarcoma (STS):: A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group.
    Pink, D
    Reichardt, P
    Nielsen, S
    Bauer, S
    Hartmann, JT
    Schöffski, P
    van Oosterom, AT
    Daugaard, S
    Stoichkov, K
    Hermans, C
    Judson, IR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 830S - 830S
  • [34] A Randomized Phase II Study of Durvalumab and Tremelimumab Compared to Doxorubicin in Patients with Advanced or Metastatic Soft Tissue Sarcoma (Medisarc, AIO-STS-0415)
    Gruenwald, Viktor
    Ivanyi, Philipp
    Hermes, Barbara
    Tuchscherer, Armin
    Pink, Daniel
    Bauer, Sebastian
    Lindner, Lars
    Augustin, Marinela
    Blocks, Andreas
    Richter, Stephan
    Reichardt, Peter
    Crysandt, Martina
    Hipper, Annette
    Fischer, Marc
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 173 - 173
  • [35] Phase II study of eribulin mesylate in patients (pts) with advanced soft tissue sarcoma (STS).
    Naito, Yoichi
    Kawai, Akira
    Araki, Nobuhito
    Ozaki, Toshifumi
    Sugiura, Hideshi
    Yazawa, Yasuo
    Morioka, Hideo
    Matsumine, Akihiko
    Hiraiwa, Masahide
    Asami, Shun
    Isu, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] ORAL PIRITREXIM - A PHASE-II STUDY IN PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMA
    SCHIESEL, JD
    CARABASI, M
    MAGILL, G
    CASPER, E
    CHENG, E
    MARKS, L
    FEYZI, J
    CLENDENINN, NJ
    SMALLEY, RV
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (02) : 97 - 98
  • [37] Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
    Takahashi, Ryuji
    Ishibashi, Yukinao
    Hiraoka, Koji
    Matsueda, Satoko
    Kawano, Kouichirou
    Kawahara, Akihiko
    Kage, Masayoshi
    Ohshima, Koichi
    Yamanaka, Ryuya
    Shichijo, Shigeki
    Shirouzu, Kazuo
    Itoh, Kyogo
    Sasada, Tetsuro
    CANCER SCIENCE, 2013, 104 (10) : 1285 - 1294
  • [38] Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
    Leahy, Michael
    Ray-Coquard, Isabelle
    Verweij, Jaap
    Le Cesne, Axel
    Duffaud, Florence
    Hogendoorn, Pancras C. W.
    Fowst, Camilla
    de Balincourt, Christine
    di Paola, Eugenio Donato
    van Glabbeke, Martine
    Judson, Ian
    Blay, Jean-Yves
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 308 - 315
  • [39] A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
    Talbot, SM
    Keohan, ML
    Hesdorffer, M
    Orrico, R
    Bagiella, E
    Troxel, AB
    Taub, RN
    CANCER, 2003, 98 (09) : 1942 - 1946
  • [40] Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc).
    Reichardt, Peter
    Andreou, Dimosthenis
    Floercken, Anne
    Gross, Thorben
    Richter, Stephan
    Kessler, Torsten
    Kortuem, Martin
    Schmidt, Christian Andreas
    Kasper, Bernd
    Wardelmann, Eva
    Benedict, Atzler
    Sookthai, Disorn
    Mueller, Daniel Wilhelm
    Pink, Daniel
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345